Top Story

Testosterone therapy did not increase prostate cancer risk in hypogonadal men

December 3, 2014

Read the Perspective from Abraham Morgentaler, MD, FACS

Hypogonadal men treated with testosterone therapy are not at increased risk for prostate cancer, according to research published in The Journal of Urology.

Ahmad Haider, MD, PhD, a urologist in Bremerhaven, Germany, and colleagues said testosterone treatment is safe in hypogonadal men if therapy guidelines are properly applied.

In the Journals

Olaparib induced tumor response in patients with germline BRCA1/BRCA2 mutations

December 1, 2014
Olaparib monotherapy induced responses across tumor types in patients with germline BRCA1 or BRCA2 mutations, according to results of a multicenter phase 2 study.The…
In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related neuroendocrine…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the JournalsPerspective

Testosterone therapy did not increase prostate cancer risk in hypogonadal men

December 3, 2014
Hypogonadal men treated with testosterone therapy are not at increased risk for prostate cancer, according to research published in The Journal of
In the Journals

Olaparib induced tumor response in patients with germline BRCA1/BRCA2 mutations

December 1, 2014
Olaparib monotherapy induced responses across tumor types in patients with germline BRCA1 or BRCA2 mutations, according to results of a multicenter…
In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
Ruth Etzioni, MD In the Journals

PSA increase after radical prostatectomy may not predict recurrence

November 18, 2014
Among patients with prostate cancer who have undergone radical prostatectomy, increases in PSA may not be predictive of progression to metastatic…
In the Journals

Radium-223 dichloride effective in CRPC, regardless of prior docetaxel

November 6, 2014
Radium Ra 223 dichloride appeared safe and effective in patients with castration-resistant prostate cancer and symptomatic bone metastases regardless…
In the Journals

ADT raised risk for cardiac death in men with prostate cancer

October 29, 2014
In men receiving treatment for prostate cancer, androgen deprivation therapy was associated with excess risk for cardiac-related death in those with…
In the Journals

Tumor characteristics influenced impact of adjuvant radiotherapy in prostate cancer

October 23, 2014
Tumor characteristics considerably influenced the impact of adjuvant radiotherapy on survival outcomes in patients with node-positive prostate…
Male pattern baldness increased risk for aggressive prostate cancer In the Journals

Male pattern baldness increased risk for aggressive prostate cancer

October 17, 2014
Men who exhibited frontal plus moderate vertex baldness by age 45 years were at increased risk for developing aggressive prostate cancer, according…
Anja Mehnert, PhD In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
More Headlines »
morganatic-roan